Figure 7.
Effects of PDM‐042 (A) and olanzapine (B) on plasma glucose levels during intraperitoneal glucose tolerance tests in rats. PDM‐042 (0.1–3 mg/kg, p.o.) or olanzapine (1–10 mg/kg, s.c.) was administered 60 min before intraperitoneal glucose challenge (2 g/kg, i.p.). Data are expressed as mean ± S.E.M. of 7–8 animals. Asterisks represent a significant difference from the vehicle‐treated group, **P < 0.01 (Dunnett's test).